Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz Tablets
Fixed-Dose Antiretroviral Combination
Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz Tablets
Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz Tablets (Virarazer). High-quality, reliable, affordable medicine.
Formulation
Tablets
Standard
WHO-GMP Certified Quality
Supply Type
Global Export & Institutional Supply
Finished Commercial Brand
Available finished formulation under our brand name Virarazer.
View Commercial Product Details
WHO-GMP Certified
Global Export Ready
Quality Assured
Formulation Insights
Comprehensive Medical Overview
Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz Tablets
Classification: Fixed-Dose Antiretroviral Combination
About Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz Tablets
A complete once-daily fixed-dose triple-combination antiretroviral therapy (Tenofovir DF, Emtricitabine, and Efavirenz) indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients.
Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz Tablets (Virarazer) Manufactured by Aprazer Healthcare
Virarazer is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.